Morgan Stanley 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-10-12 4:18 pm Sale | 2021-09-30 | 13G | Aprea Therapeutics, Inc. APRE | MORGAN STANLEY MS | 9,248 0.900% | -44,372 (-82.75%) | Filing |
| 2021-03-24 5:13 pm Purchase | 2021-03-15 | 13G | Aprea Therapeutics, Inc. APRE | MORGAN STANLEY MS | 53,621 5.100% | 53,621 (New Position) | Filing |